F. Chau

571 total citations
26 papers, 423 citations indexed

About

F. Chau is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, F. Chau has authored 26 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Molecular Medicine and 9 papers in Pharmacology. Recurrent topics in F. Chau's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). F. Chau is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). F. Chau collaborates with scholars based in France, Switzerland and Mali. F. Chau's co-authors include B. Fantin, Francis Derouin, J J Pocidalo, Laurent Massias, B Rouveix, Victoire de Lastours, Monique Brun-Pascaud, François Guérin, Vincent Cattoir and Étienne Ruppé and has published in prestigious journals such as The Journal of Infectious Diseases, Ophthalmology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

F. Chau

25 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Chau France 14 209 190 111 88 78 26 423
Jüri Teras Estonia 7 145 0.7× 69 0.4× 103 0.9× 39 0.4× 46 0.6× 19 404
Salih Türkoğlu Türkiye 9 356 1.7× 118 0.6× 87 0.8× 13 0.1× 112 1.4× 20 500
Lúcia Helena Vitali Brazil 8 113 0.5× 180 0.9× 38 0.3× 31 0.4× 59 0.8× 14 396
S Ozeki Japan 10 218 1.0× 127 0.7× 128 1.2× 11 0.1× 90 1.2× 16 443
M Meyran France 9 229 1.1× 136 0.7× 108 1.0× 10 0.1× 68 0.9× 63 414
Yoko Takayama Japan 9 128 0.6× 100 0.5× 46 0.4× 39 0.4× 30 0.4× 42 348
G. Couetdic France 9 90 0.4× 55 0.3× 35 0.3× 20 0.2× 75 1.0× 16 246
Eva M. González‐Barberá Spain 9 94 0.4× 58 0.3× 21 0.2× 37 0.4× 78 1.0× 14 288
Rosemol Varghese India 11 71 0.3× 225 1.2× 34 0.3× 33 0.4× 42 0.5× 25 352
Ali F. Aboklaish United Kingdom 8 170 0.8× 77 0.4× 75 0.7× 9 0.1× 52 0.7× 13 282

Countries citing papers authored by F. Chau

Since Specialization
Citations

This map shows the geographic impact of F. Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Chau more than expected).

Fields of papers citing papers by F. Chau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Chau. The network helps show where F. Chau may publish in the future.

Co-authorship network of co-authors of F. Chau

This figure shows the co-authorship network connecting the top 25 collaborators of F. Chau. A scholar is included among the top collaborators of F. Chau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Chau. F. Chau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chau, F., et al.. (2020). Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model. Clinical Microbiology and Infection. 26(10). 1416.e5–1416.e9. 5 indexed citations
2.
Fantin, B., Nicolas Grégoire, F. Chau, et al.. (2019). The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis. Clinical Microbiology and Infection. 25(12). 1563.e5–1563.e8. 13 indexed citations
3.
Guérin, François, Laurent Massias, F. Chau, et al.. (2018). Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli. Journal of Antimicrobial Chemotherapy. 73(11). 3074–3080. 21 indexed citations
4.
Pourbaix, Annabelle, François Guérin, Victoire de Lastours, et al.. (2017). Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection. International Journal of Medical Microbiology. 307(8). 452–459. 16 indexed citations
5.
Alexandre, Kévin, F. Chau, François Guérin, et al.. (2016). Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli. Journal of Antimicrobial Chemotherapy. 71(7). 1899–1904. 22 indexed citations
6.
Bernard, J.K., Laurence Armand-Lefèvre, Edward A. Luce, et al.. (2016). Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae. Clinical Microbiology and Infection. 22(7). 646.e1–646.e4. 12 indexed citations
7.
Lastours, Victoire de, Alexandre Bleibtreu, F. Chau, et al.. (2013). Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle. Journal of Antimicrobial Chemotherapy. 69(3). 761–768. 14 indexed citations
8.
Ruppé, Étienne, A. Pitsch, Florence Tubach, et al.. (2011). Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. European Journal of Clinical Microbiology & Infectious Diseases. 31(3). 319–325. 32 indexed citations
9.
Chau, F., A. Lefort, & B. Fantin. (2008). Intérêt et applications de la cytométrie de flux en bactériologie médicale. 10(4). 226–231. 1 indexed citations
10.
Chau, F., et al.. (2005). The Diagnostic Yield of the Evaluation for Isolated Unexplained Optic Atrophy. Ophthalmology. 112(5). 757–759. 22 indexed citations
11.
Brun-Pascaud, Monique, F. Chau, Francis Derouin, & PM Girard. (1998). Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. Journal of Antimicrobial Chemotherapy. 41(suppl 2). 57–62. 3 indexed citations
12.
Sirohi, Rajpal S., et al.. (1998). <title>Optical strain gauge</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3407. 324–327. 2 indexed citations
13.
Brun-Pascaud, Monique, F. Chau, Francis Derouin, & Pierre‐Marie Girard. (1996). Lack of activity of artemether for prophylaxis and treatment oftoxoplasma gondiiandPneumocystis cariniiinfections in rat. Parasite. 3(2). 187–189. 9 indexed citations
14.
Lacroix, Christophe, Monique Brun-Pascaud, Caroline Maslo, et al.. (1996). Co-infection of Toxoplasma gondii with Other Pathogens: Pathogenicity and Chemotherapy in Animal Models. PubMed. 219. 223–233. 2 indexed citations
15.
Grassi, Fernanda, Christian Perronne, Yves Cohen, et al.. (1996). Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection. Infection and Immunity. 64(4). 1203–1207. 5 indexed citations
16.
Brun-Pascaud, Monique, F. Chau, A.-M. Simonpoli, et al.. (1994). Experimental Evaluation Of Combined Prophylaxis Against Murine Pneumocystosis And Toxoplasmosis. The Journal of Infectious Diseases. 170(3). 653–658. 22 indexed citations
17.
Chau, F., et al.. (1993). Prognostic value of phenotypic alterations in blood lymphocyte subsets in a murine retrovirus-induced immunodeficiency syndrome (MAIDS). Clinical & Experimental Immunology. 91(3). 467–472. 7 indexed citations
18.
Derouin, Francis, et al.. (1992). Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrobial Agents and Chemotherapy. 36(12). 2852–2855. 10 indexed citations
19.
Derouin, Francis, et al.. (1992). Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Antimicrobial Agents and Chemotherapy. 36(5). 997–1001. 32 indexed citations
20.
Derouin, Francis, Christophe Piketty, Claude Chastang, et al.. (1991). Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine. Antimicrobial Agents and Chemotherapy. 35(2). 252–255. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jüri Teras Breakdown of academic impact, for papers by Salih Türkoğlu Breakdown of academic impact, for papers by Lúcia Helena Vitali Breakdown of academic impact, for papers by S Ozeki Breakdown of academic impact, for papers by M Meyran Breakdown of academic impact, for papers by Yoko Takayama Breakdown of academic impact, for papers by G. Couetdic Breakdown of academic impact, for papers by Eva M. González‐Barberá Breakdown of academic impact, for papers by Rosemol Varghese Breakdown of academic impact, for papers by Ali F. Aboklaish
Rankless by CCL
2026